Lee, Hans C. http://orcid.org/0000-0001-8545-3292
Ailawadhi, Sikander
Gasparetto, Cristina J.
Jagannath, Sundar
Rifkin, Robert M.
Durie, Brian G. M.
Narang, Mohit
Terebelo, Howard R.
Toomey, Kathleen
Hardin, James W.
Wagner, Lynne
Omel, James L.
Dhalla, Mazaher
Liu, Liang
Joshi, Prashant
Abonour, Rafat
Abonour, Rafat
,
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 14 December 2020
Revised: 16 June 2021
Accepted: 5 July 2021
First Online: 23 July 2021
Competing interests
: H.C.L. consultancy/advisory role with Adaptive Biotechnologies, Amgen, Celgene, a Bristol Myers Squibb Company, Genentech, GlaxoSmithKline, Janssen, Sanofi, and Takeda Pharmaceutical; research funding from Amgen, Celgene, a Bristol Myers Squibb Company, Daiichi Sankyo, Eutropics Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutical, Regeneron, and Takeda Pharmaceutical; S.A. consultancy/advisory role with Takeda, Novartis, Celgene, a Bristol Myers Squibb Company, Amgen; research funding from Pharmacyclics LLC, an AbbVie Company; C.J.G. receives honoraria from Janssen, Bristol Myers Squibb, Celgene, a Bristol Myers Squibb Company, and Takeda; consultancy/advisory role with Janssen, Bristol Myers Squibb, and Celgene, a Bristol Myers Squibb Company; travel, accommodations, or other expenses paid by Janssen, Bristol Myers Squibb, and Celgene, a Bristol Myers Squibb Company; research funding from Celgene, a Bristol Myers Squibb Company; S.J. consultancy/advisory role with Celgene, a Bristol Myers Squibb Company, Bristol Myers Squibb, Novartis, Merck; speakers’ bureau for MMRF and Medicom; R.M.R. consultancy/advisory role with Amgen, Boehringer Ingelheim, Celgene, a Bristol Myers Squibb Company, EMD Serono, Sandoz, and Takeda; stock with McKesson; B.G.M.D. consultancy/advisory role with Takeda and Janssen; M.N. consultancy/advisory role with and speakers’ bureau for Celgene, a Bristol Myers Squibb Company; speakers’ bureau for Janssen; H.R.T. consultancy/advisory role with Celgene, a Bristol Myers Squibb Company; speakers’ bureau for Janssen, Takeda, and Pharmacyclics LLC, an AbbVie Company; K.T. consultancy/advisory role with Celgene, a Bristol Myers Squibb Company; J.W.H. consultancy/advisory role with Celgene, a Bristol Myers Squibb Company; L.W. consultancy/advisory role with EveryFit, Gilead, and Janssen; J.L.O. receives honoraria from Takeda Oncology and Celgene, a Bristol Myers Squibb Company; board of directors/advisory committee for Takeda Oncology and Celgene, a Bristol Myers Squibb Company; M.D. employment and stock ownership at Bristol Myers Squibb; L.L. employment at Bristol Myers Squibb; P.J. employment at Bristol Myers Squibb; R.A. steering committee member for and research funding from Celgene, a Bristol Myers Squibb Company, and Takeda; research funding for Prothena.